Abdul-Hamid Bazarbachi

17PUBLICATIONS
38CO-AUTHORS
Gene and molecular therapyAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Transplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 10, 2026
Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making.

|Dec 31, 2025
Kinetics of hematologic response in AL amyloidosis: Insights from clinical and cytogenetic subgroup analysis in the daratumumab era.

Abdul-Hamid Bazarbachi, Saurabh Zanwar, Ute Hegenbart

|Dec 27, 2025
CAR T-cells in multiple myeloma: the race to the start line.

Abdul-Hamid Bazarbachi, Divaya Bhutani, Michael Sang Hughes

|Aug 14, 2024
Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT.

Razan Mohty, Abdul Hamid Bazarbachi, Myriam Labopin

|May 17, 2024
Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.

Abdul-Hamid Bazarbachi, Myriam Labopin, Anna Maria Raiola

|Mar 15, 2023
Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma.

Abdul-Hamid Bazarbachi, Daniel Reef, Hiba Narvel

Pageof 3

Frequent Collaborators

5 joint publications

Mohamad Mohty

4 joint publications

Florent Malard

3 joint publications

Rajshekhar Chakraborty

2 joint publications

Myriam Labopin